Welcome to Consumer Reports Advocacy

For 85 years CR has worked for laws and policies that put consumers first. Learn more about CR’s work with policymakers, companies, and consumers to help build a fair and just marketplace at TrustCR.org

Drug safety: Further actions needed to improve fda’s postmarket decision-making process

May 9, 2007
GAO_drug_safety_507
172.8 KB

GAO report found that FDA lacked clear and effective processes for making decisions about, and providing management oversight of, postmarket drug safety issues.

IssuesHealth
You Might Also Be Interested In
July 29, 2021
CR letter to Senate Judiciary Committee supporting bipartisan prescription drug antitrust bills
April 29, 2021
CR letter to House Judiciary Committee, competition in health care and pharmaceuticals
press release
December 22, 2020
Congress acts to restore competition to health insurance by removing 75-year-old antitrust exemption
December 1, 2020
Consumer Reports letter to Senate Appropriations Committee in defense of FTC Contact Lens Rule